Kairos Pharma Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 09/02/2026 | 309.83 K | $118.88 K | 100.00% | 1.45% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 231.88 K | $89.04 K | 0.00% | 1.08% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 82.09 K | $31.00 K | 100.00% | 0.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 78.92 K | $30.28 K | -29.08% | 0.37% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 63.88 K | $24.53 K | 0.00% | 0.30% |
| SEVENBRIDGE FINANCIAL GROUP, LLC | 08/12/2026 | 44.29 K | $17.09 K | 0.00% | 0.21% |
| APTUS CAPITAL ADVISORS, LLC | 08/12/2026 | 44.29 K | $16.99 K | 0.00% | 0.21% |
| JANE STREET GROUP, LLC | 08/14/2026 | 33.75 K | $12.95 K | 100.00% | 0.16% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 29.29 K | $11.24 K | 100.00% | 0.14% |
| STATE STREET CORP | 08/07/2026 | 24.10 K | $9.25 K | 0.00% | 0.11% |
| XTX TOPCO LTD | 08/14/2026 | 14.92 K | $5.72 K | 100.00% | 0.07% |
| UBS GROUP AG | 08/13/2026 | 6.26 K | $2.40 K | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 3.73 K | $1.43 K | -5.78% | 0.02% |
| BARCLAYS PLC | 08/14/2026 | 723 | $277 | 100.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kairos Pharma Ltd. institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Kairos Pharma Ltd.. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 309,834
VANGUARD CAPITAL MANAGEMENT LLC: 231,878
Virtu Financial LLC: 82,092
GEODE CAPITAL MANAGEMENT, LLC: 78,924
VANGUARD FIDUCIARY TRUST CO: 63,884
Aptus Capital Advisors, LLC: 44,286
4.52% of Kairos Pharma Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 1.11 M shares in the last 24 months. This purchase volume represents approximately $702.41 K in transactions.